Display options
Share it on

World J Hepatol. 2015 Apr 28;7(6):903-9. doi: 10.4254/wjh.v7.i6.903.

Aetiological factors of Budd-Chiari syndrome in Algeria.

World journal of hepatology

Nawel Afredj, Nawal Guessab, Abdelbasset Nani, Sid Ahmed Faraoun, Ibtissem Ouled Cheikh, Rafik Kerbouche, Djouhar Hannoun, Zine Charef Amir, Hayet Ait Kaci, Kamel Bentabak, Aurélie Plessier, Dominique-Charles Valla, Valerie Cazals-Hatem, Marie-Hélène Denninger, Tadjeddine Boucekkine, Nabil Debzi

Affiliations

  1. Nawel Afredj, Nawal Guessab, Abdelbasset Nani, Ibtissem Ouled Chikh, Rafik Kerbouche, Tadjeddine Boucekkine, Nabil Debzi, Hepatology Unit, Department of Medicine Mustapha Hospital, Algiers 16010, Algeria.

PMID: 25937867 PMCID: PMC4411532 DOI: 10.4254/wjh.v7.i6.903

Abstract

AIM: To study the clinical presentation of Budd-Chiari syndrome (BCS) and identify the aetiologies of this disease in Algeria.

METHODS: Patients with BCS, hospitalised in our unit from January 2004 until June 2010 were included and the aetiological factors were assessed. Patients presenting a BCS in the setting of advanced-stage cirrhosis or a liver transplantation were excluded from the study. The diagnosis was established when an obstruction of hepatic venous outflow (thrombosis, stenosis or compression) was demonstrated. We diagnosed myeloproliferative disease (MPD) by bone marrow biopsy and V617F JAK2 mutation. Anti-phospholipid syndrome (APLS) was detected by the presence of anticardiolipin antibodies, anti-β2 glycoprotein antibodies and Lupus anticoagulant. We also detected paroxysmal nocturnal haemoglobinuria (PNH) by flow cytometry. Celiac disease and Behçet disease were systematically investigated in our patients. Hereditary anticoagulant protein deficiencies were also assessed. We tested our patients for the G20210A mutation at Beaujon Hospital. Imaging procedures were performed to determine a local cause of BCS, such as a hydatid cyst or a liver tumour.

RESULTS: One hundred and fifteen patients were included. Mean follow up: 32.12 mo. Mean age: 34.41 years, M/F = 0.64. Chronic presentation was frequent: 63.5%. The revealing symptoms for the BCS were ascites (74.8%) and abdominal pain (42.6%). The most common site of thrombosis was the hepatic veins (72.2%). Involvement of the inferior vena cava alone was observed in 3 patients. According to the radiological investigations, BCS was primary in 94.7% of the cases (n = 109) and secondary in 5.2% (n = 6). An aetiology was identified in 77.4% of the patients (n = 89); it was multifactorial in 27% (n = 31). The predominant aetiology of BCS in our patients was a myeloproliferative disease, observed in 34.6% of cases. APLS was found in 21.7% and celiac disease in 11.4%. Other acquired conditions were: PNH (n = 4), systemic disease (n = 6) and inflammatory bowel disease (n = 5). Anticoagulant protein deficiency was diagnosed in 28% of the patients (n = 18), dominated by protein C deficiency (n = 13). Secondary BCS was caused by a compressing hydatic cyst (n = 5) and hepatocellular carcinoma (n = 1).

CONCLUSION: The main aetiologic factor of BCS in Algeria is MPD. The frequency of celiac disease justifies its consideration when BCS is diagnosed in our region.

Keywords: Algeria; Budd-Chiari; Celiac disease; Etiologie; Thrombosis

References

  1. Gastroenterol Hepatol. 2002 Mar;25(3):159-61 - PubMed
  2. Ann Intern Med. 2009 Aug 4;151(3):167-75 - PubMed
  3. Lancet. 1990 May 5;335(8697):1078-80 - PubMed
  4. AJR Am J Roentgenol. 2006 Mar;186(3):763-73 - PubMed
  5. Tunis Med. 1990 Jan;68(1):59-62 - PubMed
  6. Medicine (Baltimore). 2001 Nov;80(6):345-54 - PubMed
  7. Trop Gastroenterol. 1994 Jul-Sep;15(3):161-8 - PubMed
  8. Rev Esp Enferm Dig. 2001 Sep;93(9):611-2 - PubMed
  9. Leukemia. 2008 Jan;22(1):14-22 - PubMed
  10. Hepatology. 1999 Jul;30(1):84-9 - PubMed
  11. Indian J Gastroenterol. 2003 Mar-Apr;22(2):59-60 - PubMed
  12. Gastroenterol Clin Biol. 2010 Nov;34(11):621-4 - PubMed
  13. Gastroenterology. 1991 May;100(5 Pt 1):1324-31 - PubMed
  14. J Hepatol. 2003 Mar;38(3):364-71 - PubMed
  15. QJM. 1996 Jan;89(1):37-43 - PubMed
  16. Gastroenterol Clin Biol. 2003 Feb;27(2):236-7 - PubMed
  17. Arch Pediatr. 2011 Jan;18(1):102 - PubMed
  18. Eur J Radiol. 2007 Jan;61(1):44-56 - PubMed
  19. J Hepatol. 2009 Jan;50(1):195-203 - PubMed
  20. J Hepatol. 1995 Jan;22(1):1-9 - PubMed
  21. Am J Gastroenterol. 2006 Jan;101(1):83-90 - PubMed
  22. Presse Med. 1990 May 26;19(21):1011-2 - PubMed
  23. J Gastroenterol Hepatol. 1996 Feb;11(2):170-9 - PubMed
  24. Eur Radiol. 2007 Aug;17(8):2071-8 - PubMed
  25. Presse Med. 2008 Feb;37(2 Pt 1):239-41 - PubMed
  26. J Hepatol. 1994 May;20(5):650-3 - PubMed
  27. Hepatology. 2001 Oct;34(4 Pt 1):666-70 - PubMed
  28. Hepatol Res. 2007 Mar;37(3):196-204 - PubMed
  29. Hepatology. 2004 Feb;39(2):500-8 - PubMed
  30. World J Gastroenterol. 2008 May 14;14 (18):2858-62 - PubMed
  31. J Gastroenterol Hepatol. 2000 May;15(5):550-4 - PubMed
  32. Blood. 2007 Dec 1;110(12):4123-8 - PubMed
  33. J Hepatol. 2009 Oct;51(4):696-706 - PubMed
  34. Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):903-5 - PubMed
  35. Rev Med Interne. 2010 Feb;31(2):160-2 - PubMed
  36. Dig Liver Dis. 2004 Feb;36(2):157-62 - PubMed
  37. World J Gastroenterol. 2008 Jan 14;14(2):278-85 - PubMed

Publication Types